Details for New Drug Application (NDA): 090313
✉ Email this page to a colleague
The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 090313
Tradename: | SODIUM POLYSTYRENE SULFONATE |
Applicant: | Upsher Smith Labs |
Ingredient: | sodium polystyrene sulfonate |
Patents: | 0 |
Suppliers and Packaging for NDA: 090313
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 090313 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0831 | 17856-0831-1 | 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0831-1) / 15 g in 1 CUP, UNIT-DOSE |
SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 090313 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0831 | 17856-0831-2 | 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0831-2) / 30 g in 1 CUP, UNIT-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL, RECTAL | Strength | 453.6GM/BOT | ||||
Approval Date: | Dec 21, 2011 | TE: | AA | RLD: | No |
Complete Access Available with Subscription